Keith Speights

Keith Speights


Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

Thumbs up from businessman

Why Gilead Sciences Stock Is Jumping Today

A Wall Street analyst upgraded the biotech stock.

Cannabis with chart going up

Meet the Marijuana Stock That's Already Doubled in 2021

Could it have even more room to run?

Vaccine bottles forming a dollar sign

Moderna CEO's 9 Words That Could Mean Billions for the Biotech

We just have to wait to find out if he's right.

Dollar sign on top of graph

These 3 Under-the-Radar Stocks Are Great Buys Right Now

You might not hear much about them, but that could be a good thing.

Telehealth - female doctor and patient

3 Telemedicine Stocks You Can Buy Right Now

Two are telemedicine leaders already, and one could be on its way to becoming a major player.

Solar panels, wind turbines

My Best Dividend Stock for 2021

There's a lot to like with this high-flying dividend stock.

3 arrows on target with dollar sign

3 Popular Robinhood Stocks That Should Make You Richer in 2021

The future looks bright for these Robinhood investor favorites.

Older woman about to get vaccine

Why the U.S. Is Running Behind With COVID-19 Vaccinations

There are multiple reasons.

Picking vaccine bottle

Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race

This small biotech could be like the tortoise in Aesop's famous fable.

Light bulb with vaccine

3 Fantastic Coronavirus Vaccine Stocks to Buy Right Now

Each has more to offer than just a COVID-19 vaccine.

Red line pointing down

Why Cardiff Oncology Stock Is Crashing Today

The biotech presented data from an early-stage study of its experimental colorectal cancer drug.

Hepatitis B syringe

Why VBI Vaccines Stock Is Vaulting Higher Today

The company reported good news from a study of its hepatitis B vaccine.

Joe Biden - US Dept of State Flickr

What Might Biden Do Differently With COVID Vaccine Rollouts?

More money could be on the way.

Smiling Warren Buffett - TMF

This Is the Best COVID Vaccine Stock Based on Warren Buffett's Investing Rules

Really only one of the legendary investor's rules are needed.

2 COVID vaccines in front of $100

Better Buy: Novavax vs. Moderna

Both of these biotechs could be big winners in the COVID-19 vaccine market.

Question mark with stock chart

Is Pfizer Stock a Buy?

Don't focus on the big drugmaker's past. Look to the future.

Digital portrait of young woman with dollar signs

3 Fantastic Growth Stocks That Could Set You Up for Life

Seriously, they could.

Dry eyes written on chalkboard

Why Aldeyra Therapeutics Stock Is Jumping Today

The company announced the pricing of a public stock offering.

Doctor with vaccine syringe and question mark

Will the New Coronavirus Strain Affect Vaccines' Efficacy?

There's good news.

COVID vaccine and syringe with US flag

How Soon Could AstraZeneca's COVID Vaccine Be Available in the U.S.?

Emergency use authorization probably isn't imminent.